Zhao Yan D, Qu Yongming, Rahardja Dewi
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
J Biopharm Stat. 2006;16(6):803-15. doi: 10.1080/10543400600762939.
The van Elteren test, as a type of stratified Wilcoxon-Mann-Whitney test for comparing two treatments accounting for stratum effects, has been used to replace the analysis of variance when the normality assumption was seriously violated. The sample size estimation methods for the van Elteren test have been proposed and evaluated previously. However, in designing an active-comparator trial where a sample of responses from the new treatment is available but the patient response data to the comparator are limited to summary statistics, the existing methods are either inapplicable or poorly behaved. In this paper we develop a new method for active-comparator trials assuming the responses from both treatments are from the same location-scale family. Theories and simulations have shown that the new method performs well when the location-scale assumption holds and works reasonably when the assumption does not hold. Thus, the new method is preferred when computing sample sizes for the van Elteren test in active-comparator trials.
范·埃尔滕检验作为一种用于比较两种处理并考虑分层效应的分层威尔科克森-曼-惠特尼检验,在正态性假设严重违背时已被用于替代方差分析。范·埃尔滕检验的样本量估计方法此前已被提出并评估。然而,在设计一项活性对照试验时,若有来自新治疗的反应样本,但对照治疗的患者反应数据仅限于汇总统计量,现有方法要么不适用,要么表现不佳。在本文中,我们针对活性对照试验开发了一种新方法,假设两种治疗的反应均来自同一位置-尺度族。理论和模拟表明,当位置-尺度假设成立时,新方法表现良好,而当假设不成立时也能合理发挥作用。因此,在活性对照试验中为范·埃尔滕检验计算样本量时,新方法更受青睐。